257 followers
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients https://t.co/Cv4RAYLjcb
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients https://t.co/Cv4RAYLjcb
New article: Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients https://t.co/dB3SRXOuOl #livercancer #oncology https://t.co/1sHtHvyHd8